Labcorp is the blood-testing giant: when your doctor orders labs, they often end up here. Think of it as the Amazon of diagnostics, processing millions of samples daily for hospitals, clinics, and drug trials.
Money comes from routine lab tests and specialized diagnostics for pharma. Gross margin sits around 28%, net margin near 7% — a high-volume, low-margin utility. Revenue is recurring because doctors keep ordering tests, but pricing pressure from insurers keeps
Scale and an entrenched national lab network create real barriers — Quest Diagnostics is the main rival, but building comparable infrastructure takes decades. However, hospital in-house labs and upstarts like Exact Sciences are nibbling at high-margin niches,
Hold (sector percentile 31) — value B, growth B, profitability C, momentum B-, revisions C. Updated daily, sector-relative, identical for every user.
Key events, in time order
Collaboration supports leadership development, practice improvement and innovation across U.S. community health centers, expanding service reach
FDA-cleared PGDx elio tissue complete CDx identifies advanced melanoma patients with certain BRAF variants for targeted therapy eligibility
Revenue $3.73B up 5.8% YoY, diluted EPS $3.64; full-year guidance raised
Despite beat and raise, stock drops 6%, indicating market concerns
None yet
None yet
Labcorp Holdings ($LH) is highlighted as a signal strength stock in healthcare, indicating positive momentum and a potential long position.
Main discussion
All these stocks hit new 52 WEEK HIGHS at some point today Coca-Cola $KO Argenx $ARGX Waters $WAT Bio-Rad Laboratories $BIO Praxis Precision Medicines $PRAX Marathon Petroleum $MPC Valero Energy $VLO Nordson $NDSN Laboratory Corp of America $LH Natera $NTRA Targa Resources $TRGP
$LH is another Signal Strength Stocks (quantamental stock picking product) Healthcare Long by Dr. Tobin @HedgeyeHC @Mike_Taylor1972
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
